Concert Pharmaceuticals Inc (NASDAQ:CNCE)
| 4.97 Delayed Data As of Nov 28 |  -0.11 / -2.17%Today’s Change | 2.57 Today|||52-Week Range 7.37 | +57.78% Year-to-Date |
Latest CNCE News | Press Releases
No recent news for Concert Pharmaceuticals Inc.
Today’s Trading
| Previous close | 5.08 |
| Today’s open | 5.00 |
| Day’s range | 4.95 - 5.08 |
| Volume | 5,495 |
| Average volume (3 months) | 508,588 |
| Market cap | $246.9M |
Data as of 4:00pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | +2.91% |
| Earnings growth (this year) | -18.80% |
| Earnings growth (next 5 years) | +10.90% |
| Revenue growth (last year) | +312.28% |
| P/E ratio | NM |
| Price/Sales | 3.33 |
| Price/Book | 1.59 |
Competitors
Data as of 4:00pm ET, 11/28/2022
Financials
| Next reporting date | March 2, 2023 |
| EPS forecast (this quarter) | -$0.64 |
| Annual revenue (last year) | $32.6M |
| Annual profit (last year) | -$80.1M |
| Net profit margin | -245.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
